FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure

Fast Track Designation Highlights the Urgent Need for New Heart Failure Treatment Options THOUSAND OAKS, CA…

Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia

(STL.News) –  Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) approved Amgen’s…

Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen’s Myeloma MVP™ Team

(STL.News) – Amgen (NASDAQ:AMGN) today announced the expansion of Myeloma MVP™, a national initiative to help…